KEGG   DRUG: Belagenpumatucel-L
Entry
D06563                      Drug                                   
Name
Belagenpumatucel-L (USAN);
Lucanix (TN)
Efficacy
Antineoplastic
  Type
Cellular therapy product
Comment
Allogeneic vaccine cocktail of TGF-beta blocked, whole non-small cell lung cancer tumor cells.
Cell therapy treatment of non-small cell lung cancer
Target
TGFB2 [HSA:7042] [KO:K13376]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04350  TGF-beta signaling pathway
hsa05200  Pathways in cancer
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Transforming growth factors (RSTK-binding)
    TGFB2
     D06563  Belagenpumatucel-L (USAN)
Other DBs
PubChem: 47208219

» Japanese version   » Back

  All links  
Ontology (1)   
   KEGG BRITE (1)   
Chemical substance (1)   
   PubChem (1)   
Gene (2)   
   KEGG ORTHOLOGY (1)   
   KEGG GENES (1)   
All databases (4)   

Download RDF
DBGET integrated database retrieval system